Manipal Hospitals Eyes ₹8,300 Crore Mega IPO; Could Be India's Largest This Year
Source: Economictimes
Arth Insight · What this means for your wallet
- Manipal Health Enterprises is planning a ₹8,300 crore IPO, potentially the biggest in India this year.
- The company is backed by Temasek and has already concluded roadshows for institutional investors.
- The IPO will likely consist of a fresh issue of shares and a sale by existing shareholders.
India’s second-largest hospital chain, Manipal Health Enterprises, is preparing to go public with a potential $1 billion valuation. The IPO, backed by Singapore’s Temasek, could launch as early as July and aims for a total company valuation of ₹83,000 crore.
- ▸Manipal Health Enterprises is planning a ₹8,300 crore IPO, potentially the biggest in India this year.
- ▸The company is backed by Temasek and has already concluded roadshows for institutional investors.
- ▸The IPO will likely consist of a fresh issue of shares and a sale by existing shareholders.
- ▸With a target valuation of ₹83,000 crore, it aims to solidify its position as India’s second-largest hospital group.
- ✓Manipal Health Enterprises is planning a ₹8,300 crore IPO, potentially the biggest in India this year.
- ✓The company is backed by Temasek and has already concluded roadshows for institutional investors.
- ✓The IPO will likely consist of a fresh issue of shares and a sale by existing shareholders.
- ✓With a target valuation of ₹83,000 crore, it aims to solidify its position as India’s second-largest hospital group.
Retail investors may soon have the opportunity to own a piece of India’s healthcare growth story. Manipal Health Enterprises, currently the country's second-largest hospital chain, is reportedly gearing up for an Initial Public Offering (IPO) that could hit the markets as early as next month. If the plans proceed, this could be the first Indian IPO to cross the billion-dollar mark in 2024.
Large Scale Valuation and Backing
The hospital chain is reportedly seeking a valuation of approximately ₹83,000 crore ($10 billion). The proposed offering is expected to be a mix of fresh equity issuance and an Offer for Sale (OFS) from existing investors. This structure allows the company to raise new capital for expansion while allowing early backers to partially exit.
Manipal Hospitals is backed by heavyweights like Temasek, the Singaporean sovereign wealth fund. Reports indicate that the company has already completed investor roadshows, a critical step where management meets with institutional investors to gauge interest and finalize the pricing strategy.
Expansion and Market Position
Over the last few years, Manipal Hospitals has aggressively expanded its footprint across India through several high-profile acquisitions. By consolidating its position, it has emerged as the primary challenger to the market leader, Apollo Hospitals. The proceeds from the fresh issue portion of the IPO are likely to be used to further strengthen its balance sheet and fund future hospital projects.
What it Means for Retail Investors
The healthcare sector in India has seen significant interest post-pandemic, with increasing insurance penetration and rising demand for quality tertiary care. For retail investors, the Manipal IPO represents a chance to invest in a scaled, diversified hospital network with a presence in major metro cities.
- Expected Launch: As early as July 2024.
- Estimated Issue Size: Roughly ₹8,300 crore ($1 billion).
- Structure: Likely a combination of new shares and sale of shares by current owners.
As the company moves closer to filing its draft papers with the market regulator, SEBI, more details regarding the price band and exact dates will emerge. For now, the market is watching closely as this could set the tone for other large-scale listings in the second half of the year.
Investment in securities market are subject to market risks. Read all the related documents carefully before investing. This is for informational purposes only and does not constitute financial advice.
IPO investments are subject to market risk and allotment. Read the RHP / prospectus before applying; grey-market premium (GMP) is unofficial and unreliable. Some listings may be sponsored. Not investment advice.
Frequently Asked Questions
When can I apply for the Manipal Hospitals IPO?
The IPO is expected to launch as early as July 2024, though official dates will only be confirmed once the company files its prospectus with SEBI.
What will the company do with the money raised?
The fresh capital raised from the IPO is expected to be used for expansion, paying down debt, and general corporate purposes.
How big is Manipal Hospitals compared to others?
Manipal is currently the second-largest hospital chain in India, positioned just behind Apollo Hospitals in terms of scale and number of beds.
Join the Arth Vani channels
Daily news summaries, IPO & market alerts on Telegram and WhatsApp.
Because you read about IPOs
IPOBreakingSnapdeal Parent AceVector's ₹420 Crore IPO Closes with 4.93x Oversubscription
AceVector, the parent company of e-commerce platform Snapdeal, has successfully closed its ₹420 crore Initial Public Offering (IPO). The public issue garnered strong investor demand, achieving an oversubscription of 4.93 times.
IPOAI Firm Anthropic Eyes IPO Amidst Revenue Surge and Steep Losses
Artificial intelligence company Anthropic is reportedly preparing for an Initial Public Offering (IPO), driven by significant revenue growth. However, the company's financial filings reveal ballooning net losses and substantial infrastructure commitments.
IPOBreakingGlobal IPO Postponements Accelerate in Q3, Companies Opt for Sidelines
Despite a strong start to the year for initial public offerings (IPOs) globally, more companies are now choosing to delay their public market debuts. This trend of accelerated postponements, observed particularly in the third quarter and exemplified by companies like Oura, suggests a shifting sentiment in the global market.
Related Stories
IPOBreakingSnapdeal Parent AceVector's ₹420 Crore IPO Closes with 4.93x Oversubscription
AceVector, the parent company of e-commerce platform Snapdeal, has successfully closed its ₹420 crore Initial Public Offering (IPO). The public issue garnered strong investor demand, achieving an oversubscription of 4.93 times.
IPOAI Firm Anthropic Eyes IPO Amidst Revenue Surge and Steep Losses
Artificial intelligence company Anthropic is reportedly preparing for an Initial Public Offering (IPO), driven by significant revenue growth. However, the company's financial filings reveal ballooning net losses and substantial infrastructure commitments.
IPOBreakingGlobal IPO Postponements Accelerate in Q3, Companies Opt for Sidelines
Despite a strong start to the year for initial public offerings (IPOs) globally, more companies are now choosing to delay their public market debuts. This trend of accelerated postponements, observed particularly in the third quarter and exemplified by companies like Oura, suggests a shifting sentiment in the global market.
IPOBreakingAcme India Industries IPO: Grey Market Premium Hints at Strong Debut
Acme India Industries' Initial Public Offering (IPO) is showing strong demand in the grey market, with its Grey Market Premium (GMP) suggesting a potential robust listing. The company has established business ties with Indian Railways.